{{Rsnum
|rsid=17108533
|Gene=MAP3K9
|Chromosome=14
|position=70783085
|Orientation=plus
|GMAF=0.08815
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MAP3K9
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 85.8 | 13.3 | 0.9
| HCB | 94.9 | 5.1 | 0.0
| JPT | 97.3 | 2.7 | 0.0
| YRI | 64.6 | 32.0 | 3.4
| ASW | 70.2 | 29.8 | 0.0
| CHB | 94.9 | 5.1 | 0.0
| CHD | 89.9 | 9.2 | 0.9
| GIH | 95.0 | 4.0 | 1.0
| LWK | 73.4 | 23.9 | 2.8
| MEX | 91.4 | 8.6 | 0.0
| MKK | 76.3 | 21.8 | 1.9
| TSI | 77.2 | 21.8 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21107309
|Trait=None
|Title=Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
|RiskAllele=
|Pval=0.000001
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}